|
341 |
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)
Behrens, Frank. - Würzburg : Universität Würzburg, 2024
|
|
|
|
342 |
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS)
Koch, Jan Christoph. - Ludwig-Maximilians-Universität München, 2024
|
|
|
|
343 |
Silexan does not affect driving performance after single and multiple dose applications: Results from a double-blind, placebo and reference-controlled study in healthy volunteers
Möller, Hans-Jürgen. - Würzburg : Universität Würzburg, 2024
|
|
|
|
344 |
Substanz P zur Behandlung exo-fokaler Degeneration dopaminerger Neurone bei Schlaganfällen
Schlüter, Franziska Katharina. - Freiburg : Universität, 2024
|
|
|
|
345 |
The Meteoritics Trial: efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis—study protocol for a randomized, double-blind, placebo-controlled, parallel-group phase II study
Kreis, Lena. - Freiburg : Universität, 2024
|
|
|
|
346 |
The oral intake of specific Bioactive Collagen Peptides (BCP) improves gait and quality of life in canine osteoarthritis patients—A translational large animal model for a nutritional therapy option
Dobenecker, Britta. - Ludwig-Maximilians-Universität München, 2024
|
|
|
|
347 |
To nie efekt placebo
München : Sony Music Entertainment, 2024-10-11
|
|
|
|
348 |
Topical Treatment Is Effective and Safe for Acute Ankle Sprains
Gerdesmeyer, Ludger. - Jena : Friedrich-Schiller-Universität Jena, 2024
|
|
|
|
349 |
Treatment of post‐treatment Lyme disease symptoms — a systematic review
Dersch, Rick. - Freiburg : Universität, 2024
|
|
|
|
350 |
Triheptanoin Did Not Show Benefit versus Placebo for the Treatment of Paroxysmal Movement Disorders in Glut1 Deficiency Syndrome: Results of a Randomized Phase 3 Study
De Giorgis, Valentina. - Aachen : Universitätsbibliothek der RWTH Aachen, 2024
|
|
Administration
